Why did ENDV stock jump on 13 Feb 2026?

ENDV stock moved on low-float liquidity and intraday buying; volume reached **999,999** shares. Small-cap biotech names like Endonovo often react sharply to press or trading interest rather than material changes to fundamentals.

What are the main financial risks for ENDV?

Key risks include **EPS -0.01 USD**, negative book value, a current ratio near **0.00065**, and a small market cap of **$15,938.00 USD**, which increase insolvency and dilution risk for Endonovo and ENDV stock holders.

What price targets and forecast exist for ENDV stock?

We show scenario targets: bearish **$0.00001**, base **$0.0001**, bullish **$0.0003**. Meyka AI's model projects **$0.0000 USD**; forecasts are model-based projections and not guarantees.

Should investors buy ENDV stock now?

ENDV stock is highly speculative. Meyka AI rates it **66.26/100 (B, HOLD)**, but external screening lists **C- / Strong Sell**. Investors should limit position size, expect high volatility, and conduct independent due diligence.

US Stocks

ENDV stock jumps to $0.0001 on heavy volume PNK 13 Feb 2026: key signals to watch

ByDanny Kontos February 13, 2026February 13, 2026

ENDV stock opened the market on 13 Feb 2026 at $0.0001 on the PNK exchange in the United States after a sharp intraday rise. The price move represents a 9,900.00% change from the previous close of $0.000001 on very high activity, with reported volume at 999,999 shares. Traders are reacting to thin liquidity, micro-cap volatility, and company-level news flow that keeps short-term momentum intact while fundamentals remain fragile.